Linda M. Lambert

Linda M. Lambert

Auto-generated profile, based on publicly available information

Linda M. Lambert

University of Utah Health

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2022 in Pediatric Transplantation
Verified
Journal Article
Closed access
EGEric R. Griffiths
Eric R. Griffiths
LLLinda M. Lambert
Linda M. Lambert
ZOZhining Ou
Zhining Ou
ASAkraam Shaaban
Akraam Shaaban
MRMaryam Rezvani
Maryam Rezvani
KMKimberly M. Molina
Kimberly M. Molina

28 October 2025 in Circulation
Verified
Journal Article
Closed access
TMThomas A. Miller
Thomas A. Miller
BSBinu Sharma
Binu Sharma
RGRussell Gongwer
Russell Gongwer
FTFelicia L. Trachtenberg
Felicia L. Trachtenberg
JNJane W. Newburger
Jane W. Newburger
DIDawn Ilardi
Dawn Ilardi
BACKGROUND: Neurodevelopmental and functional impairments are among the most consequential morbidities for survivors of hypoplastic left heart syndrome after staged single ventricle surgical palliation. The SVRIII trial (Long-Term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type) enrolled adolescents, who were randomized to different surgical shunt types at the time of Norwood procedure as neonates, for multifaceted in-person evaluation. This study reports their neurodevelopmental outcomes. METHODS: Transplant-free survivors from SVRIII were invited to complete an in-person comprehensive neurodevelopmental evaluation in early adolescence. Outcomes across domains of cognition, academics, learning, memory, and attention, as well as social, emotional, behavioral, adaptive, and executive function, were compared with those of normative populations. Associations with demographic and medical covariates, including Norwood shunt type, were also assessed. RESULTS: Among 549 participants enrolled in the SVR trial (Single Ventricle Reconstruction), 200 of the 237 SVRIII participants (84%) completed a neurodevelopmental evaluation at a mean age of 11 years (range, 10 to 14 years). SVRIII participants who did versus did not undergo evaluation were more likely to be male (63% versus 51%), to be White (87% versus 76%), and to have a higher Childhood Opportunity Index score (61±26 versus 46±39). Full-scale intelligence quotient (88±18) was significantly lower than in the normative population, with 39% >1 and 15% >2 SD below the normative mean. Similar patterns were seen for reading (38% >1 SD and 16% >2 SD below the normative mean) and math (38% >1 SD and 19% >2 SD below the normative mean) scores. Attention, executive functioning, social development, visual memory, and adaptive functioning were all more impaired than in the normative population. Measures of socioeconomic status, number of medical complications, and requirement for a gastrostomy tube were each independent predictors of neurodevelopment, with socioeconomic status the most consistently significant factor across models. Group differences by shunt type were inconsistent across neurodevelopmental domains without a clear benefit of one surgical strategy. CONCLUSIONS: In early adolescence, transplant-free survivors of surgical palliation for hypoplastic left heart syndrome show concerning impairments across all domains of neurodevelopment. The distribution of affected outcomes is broad and associated with demographic, medical, and, most frequently, socioeconomic factors. Our findings support recommendations for neurodevelopmental evaluation during adolescence to guide individualized interventions to promote educational success and psychosocial well-being. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02455531.

21 May 2025 in Cardiology in the Young
Verified
Journal Article
Open access
PDF file
LLLinda M. Lambert
Linda M. Lambert
FTFelicia Trachtenberg
Felicia Trachtenberg
RGRussell Gongwer
Russell Gongwer
TGThomas Giorgio
Thomas Giorgio
OGOlukayode Garuba
Olukayode Garuba
VPVictoria L. Pemberton
Victoria L. Pemberton
Introduction: Adolescent and parental perceptions of the Fontan Udenafil Exercise Longitudinal Assessment Randomised Controlled Trial (FUEL) and its open-label extension were examined, to identify factors affecting future research participation. Methods: A validated survey was administered at two time points to adolescents (12–19 years) and their parents to assess likes/dislikes of study participation, research team, study burden and benefits. A 5-point Likert scale (strongly disagree [−2] to strongly agree [ + 2]) was used, and scores were averaged. Regression models explored potential predictors. Open-ended questions queried the most/least appealing aspects of participation and considerations for future research. Results: Among 250 FUEL participants at 14 centres, 179 adolescent and 183 parent surveys were completed at T1 (6 months after randomisation). Perceptions of research participation were generally positive: 1.35 ± 0.45 for adolescents; 1.56 ± 0.38 ( p < 0.001) for parents. There were no significant differences between females vs. males. Themes from open-ended responses included liking to help others and themselves, liking the study team, and disliking study burden. Adolescents liked the compensation and disliked study-related testing. At T2 (end of open-label extension study), 121 adolescents and 114 parents responded. Perception scores remained high at 1.39 ± 0.51 for adolescents and 1.58 ± 0.37 for parents ( p = 0.001). There were no significant gender differences in perceptions between adolescents, but mothers had slightly better perceptions than fathers ( p = 0.004). Conclusions: Perceptions of research were positive and slightly better for parents. Study teams and compensation were key contributors to positive perceptions. Study burden and testing were viewed less favourably. Future studies should consider families’ preferences and potential barriers to participation.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
LLLinda M. Lambert
Linda M. Lambert
VPVictoria L. Pemberton
Victoria L. Pemberton
FTFelicia L. Trachtenberg
Felicia L. Trachtenberg
KUKaren Uzark
Karen Uzark
FWFrances Woodard
Frances Woodard
TMThomas A. Miller
Thomas A. Miller
Background: Growth is often impaired in infants with congenital heart disease. Poor growth has been associated with worse neurodevelopment, abnormal behavioral state, and longer time to hospital discharge. Nutritional interventions, drug therapy, and surgical palliation have varying degrees of success enhancing growth. Passive range of motion (PROM) improves somatic growth in preterm infants and is safe and feasible in infants with hypoplastic left heart syndrome (HLHS), after their first palliative surgery (Norwood procedure). Methods: This multicenter, Phase III randomized control trial of a 21-day PROM exercise or standard of care evaluates growth in infants with HLHS after the Norwood procedure will enroll 238 infants. Growth (weight-, height- and head circumference-for-age z-scores) will be compared at 4 months of age or at the pre-superior cavopulmonary connection evaluation visit, whichever comes first. Secondary outcomes include neonatal neurobehavioral patterns, neurodevelopmental assessment, and bone mineral density (BMD). Eligibility include diagnosis of HLHS or other single right ventricle anomaly, birth at ≥37 weeks gestation and Norwood procedure at <30 days of age, and family consent. Infants with known chromosomal or recognizable phenotypic syndromes associated with growth failure, listed for transplant, or expected to be discharged within 14 days of screening are excluded. Conclusions: The TEAM 4 Growth trial will make an important contribution to understanding the role of PROM on growth, neurobehavior, neuro development, and BMD in infants with complex cardiac anomalies, who are at high risk for growth failure and developmental concerns.

15 October 2026 in World Journal for Pediatric and Congenital Heart Surgery
Verified
Journal Article
Closed access
JJJeffrey Phillip Jacobs
Jeffrey Phillip Jacobs
WDWilliam M. DeCampli
William M. DeCampli
HNHani K. Najm
Hani K. Najm
OHOsami Honjo
Osami Honjo
BABahaaldin Alsoufi
Bahaaldin Alsoufi
RJRobert D. B. Jaquiss
Robert D. B. Jaquiss
The Congenital Heart Surgeons’ Society (CHSS) is viewed by many as one of the most prestigious professional societies dedicated to pediatric and congenital cardiac surgery. The CHSS Center for Research and Quality (CRQ) Fall 2025 Work Weekend was held in Chicago on Saturday, October 25, 2025. The purpose of this article is to summarize the proceedings of the CHSS CRQ Fall 2025 Work Weekend and to provide a 2025 Annual Report of the CHSS CRQ. At the CHSS CRQ Fall 2025 Work Weekend, multiple topics were discussed related to ongoing CHSS research and quality initiatives. The CHSS CRQ is evolving to keep pace with the rapid evolution of medical informatics and the ever-evolving regulatory issues of clinical research. This 2025 Annual Report of the CHSS CRQ summarizes some of the ongoing initiatives at CHSS CRQ designed to assure that the CHSS CRQ continues to lead innovative and collaborative clinical research to improve pediatric and congenital cardiac care.

31 March 2026 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
SBSamantha C. Butler
Samantha C. Butler
LMLauren Malik
Lauren Malik
PKPierce Kuhnell
Pierce Kuhnell
LLLinda M. Lambert
Linda M. Lambert
JBJennie Briend
Jennie Briend
JAJulia S. Anixt
Julia S. Anixt
Background: Infants with single ventricle CHD commonly experience gross motor delays due to physiological and environmental factors, including increased risk for white matter injury, reduced aerobic capacity, restrictive post-operative protocols, and limited movement opportunities. These delays persist in adolescence, affecting physical and social development. This study examines a quality improvement initiative within the National Pediatric Cardiology Quality Improvement Collaborative to enhance gross motor development. Methods: Fifteen centres participated. Gross motor skills were assessed using the Ages and Stages Questionnaires, Third Edition, at 6 and 12 months. A key driver diagram, Plan-Do-Study-Act cycles, baseline data, and ongoing process measures were collected. Interventions were implemented, including education, therapy support, and mobilisation protocols. Control charts were used to evaluate the data. Results: Scores from the Ages and Stages Questionnaires indicated delays in gross motor skills at baseline, with improvement over time. Participating centres showed a centerline shift from 41% to 89% of infants achieving on-target or improved motor scores, compared with 54% to 68% of infants at non-participating centres. Establishment of customised infant developmental plans increased from 62% to 74% for participating centres and from 53% to 61% for non-participating centres. Interventions included establishing processes for consistent screening, developmental plan administration, review of prone positioning, access to therapies, and early intervention referrals. Conclusion: This targeted quality improvement project increased the use of inpatient practices to support gross motor development for infants with single ventricle CHD. Collaborative, interdisciplinary efforts remain critical for addressing neurodevelopmental challenges in this high-risk population.